当前位置:首页 - 行情中心 - 和元生物(688238) - 财务分析

和元生物

(688238)

  

流通市值:51.74亿  总市值:52.38亿
流通股本:6.41亿   总股本:6.49亿

和元生物(688238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-1.04亿元,每股收益-0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益153719.24万元,未分配利润-47059.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产211945.28万元,负债58226.04万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入119,854,988.9852,847,732.33248,149,229.12183,867,467.02
营业总成本223,076,169.16114,041,714.68528,959,440.25362,113,906.26
其他经营收益
营业利润-102,473,388.34-59,085,763.39-310,450,810.31-188,736,381.74
利润总额-102,771,640.68-59,484,006.59-312,627,116.9-188,853,339.47
净利润-104,481,169.78-59,510,258.38-322,182,350.33-190,249,411.55
每股收益
其他综合收益2,124,667.76883,401.49-1,303,608.23-986,052.14
综合收益总额-102,356,502.02-58,626,856.89-323,485,958.56-191,235,463.69
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计529,235,254.03611,596,287.16690,426,516.75737,574,303.86
非流动资产:
非流动资产合计1,590,217,590.641,582,754,432.041,594,314,224.271,615,726,548.37
资产总计2,119,452,844.672,194,350,719.22,284,740,741.022,353,300,852.23
流动负债:
流动负债合计380,408,565.34365,803,331.93329,891,054.95289,945,070.68
非流动负债:
非流动负债合计201,851,848.15206,084,477.02215,302,170.84195,262,087.45
负债合计582,260,413.49571,887,808.95545,193,225.79485,207,158.13
所有者权益(或股东权益):
归属于母公司股东权益合计1,537,348,193.91,622,740,580.831,739,792,228.871,868,451,713.36
股东权益合计1,537,192,431.181,622,462,910.251,739,547,515.231,868,093,694.1
负债和股东权益合计2,119,452,844.672,194,350,719.22,284,740,741.022,353,300,852.23
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计113,804,199.6445,090,645.59370,607,973.2203,124,804.74
经营活动现金流出小计202,303,817.23106,504,327.14431,676,451.5334,974,776.57
经营活动产生的现金流量净额-88,499,617.59-61,413,681.55-61,068,478.3-131,849,971.83
投资活动产生的现金流量:
投资活动现金流入小计209,664,967.6590,580,816.32179,426,819.8538,781,365.72
投资活动现金流出小计291,056,857.78150,952,902.19388,457,233.05271,142,225.97
投资活动产生的现金流量净额-81,391,890.13-60,372,085.87-209,030,413.2-232,360,860.25
筹资活动产生的现金流量:
筹资活动现金流入小计200,000,000180,000,00093,704,31690,000,000
筹资活动现金流出小计182,568,483.3137,616,060.4841,495,297.2738,431,225.17
筹资活动产生的现金流量净额17,431,516.742,383,939.5252,209,018.7351,568,774.83
汇率变动对现金及现金等价物的影响-23,479.12-5,811.58-202,675.37-27,425.61
现金及现金等价物净增加额-152,483,470.14-79,407,639.48-218,092,548.14-312,669,482.86
期末现金及现金等价物余额282,410,781.69355,486,612.35434,894,251.83340,317,317.11
补充资料:
现金及现金等价物的净增加额-152,483,470.14--218,092,548.14-
最新报告期:2025-08-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中金公司张琎,吴婉桦-0.44-0.42--2025-08-19
TOP↑